Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
Kimberly received her B.S. in Biochemistry and B.A. in Chemistry from the College of Charleston in 2011. She spent time working in formulation development at Johnson & Johnson and synthetic organic chemistry at MitoChem Therapeutics prior to completing her Ph.D. in Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus in 2020. Since her Ph.D., she has worked as a process chemist at Cambrex Corporation in Longmont, CO. In her role she is responsible for optimizing synthetic routes to active pharmaceutical ingredients for purity, safety, reproducibility, scalability, and yield. As a project lead, she is responsible for presenting work both internally and externally to clients and works directly with manufacturing colleagues to support the successful production of active pharmaceutical ingredients on the gram to kilogram scale.
PLATINUM SPONSORS:
SPONSORS: